Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
3
pubmed:dateCreated
2008-4-17
pubmed:abstractText
Hyperhomocysteinemia is regarded as an independent risk factor for cardiovascular disorders. Although renal dysfunction or failure is one of the important factors causing hyperhomocysteinemia, the role of homocysteine (Hcy) in the development of glomerulosclerosis is largely unknown. One of the key events in the pathogenesis of glomerulosclerosis is the infiltration of circulating monocytes into affected glomeruli. The objective of the present study was to investigate the effect of Hcy on the expression of monocyte chemoattractant protein-1 (MCP-1) in kidney mesangial cells and the mechanisms involved. Levels of MCP-1 and mRNA were significantly elevated in Hcy-treated rat mesangial cells. This increase was associated with activation of NF-kappaB as a result of increased phosphorylation of the inhibitor protein IkappaBalpha. Monocyte chemotactic activity in these cells was also enhanced. In addition, there was a significant elevation of superoxide anion produced by Hcy-treated cells, which preceded the increased phosphorylation of IkappaBalpha. Addition of superoxide dismutase or NF-kappaB inhibitors to the culture medium abolished Hcy-induced NF-kappaB activation and MCP-1 expression. Taken together, these results indicate that Hcy induced MCP-1 expression in mesangial cells. Such a process was mediated by oxidative stress and NF-kappaB activation. This may further aggravate renal function in patients with hyperhomocysteinemia.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Mar
pubmed:issn
0008-4212
pubmed:author
pubmed:issnType
Print
pubmed:volume
86
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
88-96
pubmed:meshHeading
pubmed-meshheading:18418435-Animals, pubmed-meshheading:18418435-Cell Movement, pubmed-meshheading:18418435-Cell Survival, pubmed-meshheading:18418435-Cells, Cultured, pubmed-meshheading:18418435-Chemokine CCL2, pubmed-meshheading:18418435-Dose-Response Relationship, Drug, pubmed-meshheading:18418435-Electrophoretic Mobility Shift Assay, pubmed-meshheading:18418435-Free Radical Scavengers, pubmed-meshheading:18418435-Homocysteine, pubmed-meshheading:18418435-Male, pubmed-meshheading:18418435-Mesangial Cells, pubmed-meshheading:18418435-Models, Biological, pubmed-meshheading:18418435-Monocytes, pubmed-meshheading:18418435-NF-kappa B, pubmed-meshheading:18418435-Nuclear Proteins, pubmed-meshheading:18418435-Oxidative Stress, pubmed-meshheading:18418435-Phosphorylation, pubmed-meshheading:18418435-Polyethylene Glycols, pubmed-meshheading:18418435-Protein Binding, pubmed-meshheading:18418435-RNA, Messenger, pubmed-meshheading:18418435-Rats, pubmed-meshheading:18418435-Rats, Sprague-Dawley, pubmed-meshheading:18418435-Reverse Transcriptase Polymerase Chain Reaction, pubmed-meshheading:18418435-Superoxide Dismutase, pubmed-meshheading:18418435-Superoxides
pubmed:year
2008
pubmed:articleTitle
Homocysteine stimulates monocyte chemoattractant protein-1 expression in mesangial cells via NF-kappaB activation.
pubmed:affiliation
Department of Animal Science, University of Manitoba, Integrative Biology Laboratory, St. Boniface Hospital Research Centre, Winnipeg, MB R2H2A6, Canada.
pubmed:publicationType
Journal Article, Research Support, Non-U.S. Gov't